Relevant nursing measures for the adverse reactions associated with chimeric antigen receptor T cells (CAR-T) immunotherapy: a systematic review of case reports†
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Ramos CA, Dotti G. Chimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapy. Expert Opin Biol Ther. 2011;11:855-873.10.1517/14712598.2011.57347621463133RamosCADottiGChimeric antigen receptor (CAR)-engineered lymphocytes for cancer therapyExpert Opin Biol Ther201111855873310737321463133Open DOISearch in Google Scholar
Firor AE, Jares A, Ma Y. From humble beginnings to success in the clinic: chimeric antigen receptor-modified T-cells and implications for immunotherapy. Exp Biol Med (Maywood). 2015;240:1087-1098.10.1177/153537021558493625956686FirorAEJaresAMaYFrom humble beginnings to success in the clinic: chimeric antigen receptor-modified T-cells and implications for immunotherapyExp Biol Med (Maywood)201524010871098493528325956686Open DOISearch in Google Scholar
Porter DL, Levine BL, Kalos M, Bagg A, June CH. Chimeric antigen receptor–modified T cells in chronic lymphoid leukemia. N Engl J Med. 2011;365:725-733.2183094010.1056/NEJMoa1103849PorterDLLevineBLKalosMBaggAJuneCHChimeric antigen receptor–modified T cells in chronic lymphoid leukemiaN Engl J Med2011365725733338727721830940Search in Google Scholar
Zhu Y, Tan Y, Ou R, et al. Anti-cd19 chimeric antigen receptor-modified T cells for b-cell malignancies: a systematic review of efficacy and safety in clinical trials. Eur J Haematol. 2016;96:389-396.2611535810.1111/ejh.12602ZhuYTanYOuRAnti-cd19 chimeric antigen receptor-modified T cells for b-cell malignancies: a systematic review of efficacy and safety in clinical trialsEur J Haematol20169638939626115358Search in Google Scholar
Maude SL, Frey N, Shaw PA, et al. Chimeric antigen receptor T cells for sustained remissions in leukemia. N Engl J Med. 2014;371:1507-1517.10.1056/NEJMoa140722225317870MaudeSLFreyNShawPAChimeric antigen receptor T cells for sustained remissions in leukemiaN Engl J Med201437115071517426753125317870Open DOISearch in Google Scholar
Lee DW, Gardner R, Porter DL, et al. Current concepts in the diagnosis and management of cytokine release syndrome. Blood. 2014;124:188-195.10.1182/blood-2014-05-55272924876563LeeDWGardnerRPorterDLCurrent concepts in the diagnosis and management of cytokine release syndromeBlood2014124188195409368024876563Open DOISearch in Google Scholar
Grupp SA, Kalos M, Barrett D, et al. Chimeric antigen receptor–modified T cells for acute lymphoid leukemia. N Engl J Med. 2013;368:1509-1518.2352795810.1056/NEJMoa1215134GruppSAKalosMBarrettDChimeric antigen receptor–modified T cells for acute lymphoid leukemiaN Engl J Med201336815091518405844023527958Search in Google Scholar
Maus MV, Grupp SA, Porter DL, June CH. Antibody-modified T cells: cars take the front seat for hematologic malignancies. Blood. 2014;123:2625-2635.2457850410.1182/blood-2013-11-492231MausMVGruppSAPorterDLJuneCHAntibody-modified T cells: cars take the front seat for hematologic malignanciesBlood201412326252635399975124578504Search in Google Scholar
Kochenderfer JN, Dudley ME, Carpenter RO, et al. Donor-derived cd19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantation. Blood. 2013;122:4129-4139.10.1182/blood-2013-08-51941324055823KochenderferJNDudleyMECarpenterRODonor-derived cd19-targeted T cells cause regression of malignancy persisting after allogeneic hematopoietic stem cell transplantationBlood201312241294139386227624055823Open DOISearch in Google Scholar
Ke XY. Application progress of chimeric antigen receptor - T cell immunotherapy in hematological malignancies. Chin General Med. 2016;19:1361-1366 (in Chinese).KeXYApplication progress of chimeric antigen receptor - T cell immunotherapy in hematological malignanciesChin General Med20161913611366(in Chinese)Search in Google Scholar
Moga C, Guo B, Schopflocher D. Development of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique. Vol. 25. Edmonton AB: Institute of Health Economics; 2012:1262-1268.MogaCGuoBSchopflocherDDevelopment of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique. Vol. 25Edmonton ABInstitute of Health Economics201212621268Search in Google Scholar
Yu LL. Nursing care of 7 children with advanced malignant solid tumor treated with CAR-T cell combined with chemotherapy. Tianjin Nurs. 2017;25:528-529 (in Chinese).YuLLNursing care of 7 children with advanced malignant solid tumor treated with CAR-T cell combined with chemotherapyTianjin Nurs201725528529(in Chinese)Search in Google Scholar
Zhang P, Dai JX, Zhou L. Nursing care of patients with relapsed and refractory hematological malignancies undergoing CART cell therapy. Med Inf. 2016;29:226-227 (in Chinese).ZhangPDaiJXZhouLNursing care of patients with relapsed and refractory hematological malignancies undergoing CART cell therapyMed Inf201629226227(in Chinese)Search in Google Scholar
Chen XL, Feng YM, Zeng YJ, et al. Exploration of integrated nursing care on CAR-T cell immunotherapy for refractory acute lymphocytic leukemia. Chin J Blood Transfusion. 2016;29:1104-1107 (in Chinese).ChenXLFengYMZengYJExploration of integrated nursing care on CAR-T cell immunotherapy for refractory acute lymphocytic leukemiaChin J Blood Transfusion20162911041107(in Chinese)Search in Google Scholar
Feng N, Du X, Zhang C, Hao J, Zeng L. Nursing care of patients with recurrent refractory acute lymphoblastic leukemia treated with chimeric antigen receptor. Chongqing Med. 2016;45:140-141 (in Chinese).FengNDuXZhangCHaoJZengLNursing care of patients with recurrent refractory acute lymphoblastic leukemia treated with chimeric antigen receptorChongqing Med201645140141(in Chinese)Search in Google Scholar
Li LN, Wan Y. Nursing care of patients with B cell malignant tumor treated with chimeric antigen receptor modified T cell immunotherapy. Chin J Nurs. 2017;52:297-299 (in Chinese).LiLNWanYNursing care of patients with B cell malignant tumor treated with chimeric antigen receptor modified T cell immunotherapyChin J Nurs201752297299(in Chinese)Search in Google Scholar
Ding YG, Zhao W, Wu XY, Ma XL. Nursing experience of children with neuroblastoma developing adverse reaction after retransfusion of chimeric antigen receptor-transduced T-cells. Chin J Nurs. 2017;52:307-310 (in Chinese).DingYGZhaoWWuXYMaXLNursing experience of children with neuroblastoma developing adverse reaction after retransfusion of chimeric antigen receptor-transduced T-cellsChin J Nurs201752307310(in Chinese)Search in Google Scholar
Turtle CJ. Chimeric antigen receptor modified T cell therapy for B cell malignancies. Int J Hematol. 2014;99:132-140.10.1007/s12185-013-1490-x24338745TurtleCJChimeric antigen receptor modified T cell therapy for B cell malignanciesInt J Hematol20149913214024338745Open DOISearch in Google Scholar
Yamauchi K, Yang M, Hayashi K, et al. Induction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapy. Cancer Res. 2008;68:516-520.1819954710.1158/0008-5472.CAN-07-3063YamauchiKYangMHayashiKInduction of cancer metastasis by cyclophosphamide pretreatment of host mice: an opposite effect of chemotherapyCancer Res20086851652018199547Search in Google Scholar
Pan J, Yang JF, Deng BP, et al. High efficacy and safety of low-dose cd19-directed CAR-T cell therapy in 51 refractory or relapsed b acute lymphoblastic leukemia patients. Leukemia. 2017;31:2587-2593.10.1038/leu.2017.14528490811PanJYangJFDengBPHigh efficacy and safety of low-dose cd19-directed CAR-T cell therapy in 51 refractory or relapsed b acute lymphoblastic leukemia patientsLeukemia2017312587259328490811Open DOISearch in Google Scholar
Gardner RA, Finney O, Annesley C, et al. Intent to treat leukemia remission by cd19car T cells of defined formulation and dose in children and young adults. Blood. 2017;129:3322-3331.GardnerRAFinneyOAnnesleyCIntent to treat leukemia remission by cd19car T cells of defined formulation and dose in children and young adultsBlood20171293322333110.1182/blood-2017-02-769208548210328408462Search in Google Scholar
Mol MM, Boeter GW, Verharen L, Kompanje EJ, Bakker J, Nijkamp MD. Patient- and family-centered care in the intensive care unit, a challenge in the daily practice of healthcare professionals. J Clin Nurs. 2016;26:3212-3223.MolMMBoeterGWVerharenLKompanjeEJBakkerJNijkampMDPatient- and family-centered care in the intensive care unit, a challenge in the daily practice of healthcare professionalsJ Clin Nurs20162632123223Search in Google Scholar
Thuy NL, Clemenceau AL, Lebaron VT. Challenges encountered by Vietnamese nurses when caring for patients with cancer. Oncol Nurs Forum. 2017;44:147-151.28222082ThuyNLClemenceauALLebaronVTChallenges encountered by Vietnamese nurses when caring for patients with cancerOncol Nurs Forum201744147151Search in Google Scholar
Morsch CM, Gonçalves LF, Barros E. Health-related quality of life among haemodialysis patients - relationship with clinical indicators, morbidity and mortality. J Clin Nurs. 2006;15:498-504.10.1111/j.1365-2702.2006.01349.x16553764MorschCMGonçalvesLFBarrosEHealth-related quality of life among haemodialysis patients - relationship with clinical indicators, morbidity and mortalityJ Clin Nurs20061549850416553764Open DOISearch in Google Scholar
